跳至主要内容
临床试验/NCT02539264
NCT02539264已完成不适用

Impact of Smoking, BZD and Obesity on Severe Obstructive Sleep Apnea (sOSA)

Astes0 个研究点目标入组 920 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
920
主要终点
Apnea Hypopnea Index

研究概览

简要总结

In this study the investigators will analyze the influence of smoking, benzodizepine use, and obesity among patients with severe Obstructive Sleep Apnea (sOSA).

详细描述

This study is a retrospective study. Patients enrolled: all patients with a PSG (polysomnography) between 1st January 2014 and 30th June 2015.

First analysis: influence of smoking, benzodiazepine use, and obesity on the AHI (Apnea Hypopnea Index: the number of apnea and hypopnea per hour of sleep).

Second analysis: only among patients with sOSA: influence of smoking, benzodiazepine use, and obesity on sleep fragmentation and night oximetry.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • All patients registered for an overnight PSG at Clinique Saint-Luc of Bouge

排除标准

  • 未提供

结局指标

主要结局

Apnea Hypopnea Index

时间窗: 1 day

Apnea Hypopnea Index (AHI) is defined as the number of apnea and hypopnea per hour of sleep. It is the major determinant of the severity of OSA.

次要结局

  • Sleep fragmentation defined by the percentage of time spent in each of the four stades of sleep (Stade 1, Stade 2, Slow wave sleep and Rapid Eye Movements)(1 day)
  • Time spent under 90% of SpO2 during the night(1 day)

研究者

发起方
Astes
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric DEFLANDRE, MD, FCCP

MD, FCCP

Astes

相似试验